e
EXOZ
eXoZymes Inc
4.000
+0.100+2.56%After Hours: 4.000 0.000 0.00%16:10 10/23 EDT
OPEN/PREV CLOSE3.880/3.900
TODAY RANGE3.850-4.440
VOL14.31K
MARKET CAP37.22M
52 WEEK RANGE3.705-18.40
AVG VOL (3M)8.11K
% TURNOVER0.15%
TURNOVER--
P/E (TTM)-3.3289
% RANGE15.13%
EPS(TTM)-1.2016
P/E(FORWARD)-3.3613
P/B10.16
BVPS0.3937
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.89M
SHARES OUTSTANDING9.30M
NEXT EARNINGS11/09-11/16
FREE FLOAT3.22M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/09 16:27
eXoZymes Highlights Investor Presentation for Capital Markets Outreach
TipRanks·09/18 18:17
eXoZymes Sets Date for 2026 Shareholders Meeting
Benzinga·09/09 21:06
12 Health Care Stocks Moving In Wednesday's After-Market Session
TipRanks·08/25 20:00
eXoZymes Inc trading resumes
TipRanks·08/25 19:55
eXoZymes Inc trading halted, volatility trading pause
Seeking Alpha·08/20 21:26
eXoZymes reports Q2 results
Benzinga·08/20 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·07/15 13:46
eXoZymes Inc trading resumes
TipRanks·07/15 13:41
eXoZymes Inc trading halted, volatility trading pause
TipRanks·07/01 21:03
eXoZymes Completes New Securities Offering to Fund Pipeline
TipRanks·06/26 10:30
eXoZymes Secures NIH Grant to Advance Cannabinoid Pipeline
Seeking Alpha·06/24 20:21
eXoZymes awarded $2M NIH Grant to advance cannabinoid analogs for drug discovery
Benzinga·06/24 20:15
eXoZymes Wins $2M NIH Grant To Advance Cannabinoid Analogs For Drug Discovery
TipRanks·06/17 22:45
eXoZymes Completes Nasdaq Equity Offering to Fund Pipeline